Liver function tests were down-trending by the time of discharge (bilirubin: 12.2 mg/dL, AST: 74 U/L, ALT: 131 U/L). Follow-up with serial serum bilirubin, AST, and ALT levels is crucial in this case to monitor the patient's ongoing liver function. Although not all patients with a diagnosis of DILI require hepatology follow-up after acute management, referral to a transplant center is necessary if there is evidence of acute liver failure. The gene discussed is GPT; the disease is acute liver failure.